Smit EF - Search Results

1

Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial.

Ediebah DE, Coens C, Zikos E, Quinten C, Ringash J, King MT, Schmucker von Koch J, Gotay C, Greimel E, Flechtner H, Weis J, Reeve BB, Smit EF, Taphoorn MJ, Bottomley A. Ediebah DE, et al. Among authors: smit ef. Br J Cancer. 2014 May 13;110(10):2427-33. doi: 10.1038/bjc.2014.208. Epub 2014 Apr 17. Br J Cancer. 2014. PMID: 24743709 Free PMC article.

2

A phase II study of high dose epirubicin in unresectable non small cell lung cancer.

Smit EF, Berendsen HH, Piers DA, Smeets J, Riva A, Postmus PE. Smit EF, et al. Br J Cancer. 1992 Mar;65(3):405-8. doi: 10.1038/bjc.1992.82. Br J Cancer. 1992. PMID: 1313691 Free PMC article. Clinical Trial.

3

A feasibility study of testing new drugs for small-cell lung cancer in patients with a poor performance status.

Postmus PE, Smit EF, Berendsen HH, Sleyfer DT. Postmus PE, et al. Among authors: smit ef. Cancer Chemother Pharmacol. 1991;27(6):490-1. doi: 10.1007/BF00685167. Cancer Chemother Pharmacol. 1991. PMID: 1849466

4

Oral therapy for small cell lung cancer.

Postmus PE, Smit EF. Postmus PE, et al. Among authors: smit ef. Lung Cancer. 1995 Jun;12 Suppl 3:S63-70. doi: 10.1016/s0169-5002(10)80019-4. Lung Cancer. 1995. PMID: 7551958 Review.

5

Testing the possible non-cross resistance of two equipotent combination chemotherapy regimens against small-cell lung cancer: a phase II study of the EORTC Lung Cancer Cooperative Group.

Postmus PE, Smit EF, Kirkpatrick A, Splinter TA. Postmus PE, et al. Among authors: smit ef. Eur J Cancer. 1993;29A(2):204-7. doi: 10.1016/0959-8049(93)90176-g. Eur J Cancer. 1993. PMID: 8380697 Clinical Trial.

6

Phase I study of high-dose epirubicin and vinorelbine in previously untreated non-small-cell lung cancer stage IIIB-IV.

Bakker M, Groen HJ, Smit EF, Smeets J, Riggi M, Postmus PE. Bakker M, et al. Among authors: smit ef. Br J Cancer. 1995 Dec;72(6):1547-50. doi: 10.1038/bjc.1995.545. Br J Cancer. 1995. PMID: 8519675 Free PMC article. Clinical Trial.

7

A phase II study of paclitaxel in heavily pretreated patients with small-cell lung cancer.

Smit EF, Fokkema E, Biesma B, Groen HJ, Snoek W, Postmus PE. Smit EF, et al. Br J Cancer. 1998;77(2):347-51. doi: 10.1038/bjc.1998.54. Br J Cancer. 1998. PMID: 9461009 Free PMC article. Clinical Trial.

8

A dose and schedule finding study of gemcitabine and etoposide in patients with progressive non-small cell lung cancer after platinum containing chemotherapy.

Biesma B, Smit EF, Postmus PE. Biesma B, et al. Among authors: smit ef. Lung Cancer. 1999 May;24(2):115-21. doi: 10.1016/s0169-5002(99)00033-1. Lung Cancer. 1999. PMID: 10444062 Clinical Trial.

9

Second-line chemotherapy and its evaluation in small cell lung cancer.

Huisman C, Postmus PE, Giaccone G, Smit EF. Huisman C, et al. Among authors: smit ef. Cancer Treat Rev. 1999 Aug;25(4):199-206. doi: 10.1053/ctrv.1999.0125. Cancer Treat Rev. 1999. PMID: 10448128 Review.

10

Gemcitabine and paclitaxel: pharmacokinetic and pharmacodynamic interactions in patients with non-small-cell lung cancer.

Kroep JR, Giaccone G, Voorn DA, Smit EF, Beijnen JH, Rosing H, van Moorsel CJ, van Groeningen CJ, Postmus PE, Pinedo HM, Peters GJ. Kroep JR, et al. Among authors: smit ef. J Clin Oncol. 1999 Jul;17(7):2190-7. doi: 10.1200/JCO.1999.17.7.2190. J Clin Oncol. 1999. PMID: 10561275 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

514 results

Search Page